Accelerate Diagnostics
AXDX
#10564
Rank
A$1.23 M
Marketcap
A$0.04882
Share price
0.00%
Change (1 day)
-97.78%
Change (1 year)

Earnings for Accelerate Diagnostics (AXDX)

Earnings in 2024 (TTM): -A$55.8 Million

According to Accelerate Diagnostics's latest financial reports the company's current earnings are A$11.69 Million. , an increase over its 2023 earnings that were of -A$76.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Accelerate Diagnostics from 1998 to 2024

Annual earnings

Year Earnings Change
2024 -A$53.13 Million-30.23%
2023 -A$76.15 Million-10.11%
2022 -A$84.71 Million-5.02%
2021 -A$89.2 Million-0.87%
2020 -A$89.98 Million-10.7%
2019 -A$0.11 Billion-10.05%
2018 -A$0.12 Billion22.77%
2017 -A$91.24 Million-4%
2016 -A$95.04 Million47.64%
2015 -A$64.38 Million42.74%
2014 -A$45.1 Million105.26%
2013 -A$21.98 Million
2011 -A$1.71 Million-182.9%
2010 A$2.05 M-219.16%
2009 -A$1.73 Million6.65%
2008 -A$1.62 Million-40.67%
2007 -A$2.73 Million14.69%
2006 -A$2.38 Million399.94%
2005 -A$0.48 Million
2001 -A$1.65 Million-52.29%
2000 -A$3.46 Million53.4%
1999 -A$2.26 Million-282.93%
1998 A$1.23 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
A$10.18 B-19,280.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$2.70 B-5,187.17%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
A$0.68 B-1,382.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bruker
BRKR
A$0.10 B-301.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
-A$0.23 Billion 328.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
-A$1.21 Billion 2,177.65%๐Ÿ‡บ๐Ÿ‡ธ USA